MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1183/13993003.01683-2015

Медицинская библиотека · The European respiratory journal · 2016

Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial.

Araujo Mariana S, Baldi Bruno G, Freitas Carolina S G, Albuquerque André L P, Marques da Silva Cibele C B, Kairalla Ronaldo A, Carvalho Celso R F, Carvalho Carlos R R

Контролируемое клиническое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Lymphangioleiomyomatosis (LAM) is a cystic lung disease frequently associated with reduced exercise capacity. The aim of this study was to assess safety and efficacy of pulmonary rehabilitation in LAM.This controlled clinical trial included 40 patients with LAM and a low physical activity level. The pulmonary rehabilitation programme comprised 24 aerobic and muscle strength training sessions and education. The primary outcome was exercise capacity (endurance time during a constant work rate exercise test). Secondary outcomes included health-related quality of life (St George's Respiratory Questionnaire (SGRQ)), 6-min walking distance (6MWD), dyspnoea, peak oxygen consumption (V'O2 ), daily physical activity (pedometer), symptoms of anxiety and depression, lung function and peripheral muscle strength (one-repetition maximum).The baseline characteristics were well balanced between the groups. The pulmonary rehabilitation group exhibited improvements in the following outcomes versus controls: endurance time (median (interquartile range) 169 (2-303) s versus -33 (-129-39) s; p=0.001), SGRQ (median (interquartile range) -8 (-16-2) versus 2 (-4-5); p=0.002) and 6MWD (median (interquartile range) 59 (13-81) m versus 20 (-12-30) m; p=0.002). Dyspnoea, peak V'O2 , daily physical activity and muscle strength also improved significantly. No serious adverse events were observed.Pulmonary rehabilitation is a safe intervention and improves exercise capacity, dyspnoea, daily physical activity, quality of life and muscle strength in LAM.

Для цитирования: Araujo Mariana S, Baldi Bruno G, Freitas Carolina S G, Albuquerque André L P, Marques da Silva Cibele C B, Kairalla Ronaldo A, Carvalho Celso R F, Carvalho Carlos R R. Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial.. The European respiratory journal. 2016. DOI: 10.1183/13993003.01683-2015.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.